Notice of Award: ERVEBO
Award Notice Posted
A later notice was posted: the Limited / Sole Source Justification from .
- Solicitation number
- 75A50124C00057
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Merck Sharp & Dohme LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50124C00057 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Washington, District of Columbia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a contract to Merck Sharp & Dohme LLC for the procurement of a FDA licensed Zaire ebolavirus vaccine, ERVEBO, to be stored in vendor managed inventory. The contract, valued at $174,606,743.00, will allow the agency to invest Project Bioshield funds for the vaccine's final drug product and the development of an updated manufacturing process.
Notice text
This acquisition will allow BARDA to invest Project Bioshield funds for the procurement of a FDA licensed Zaire ebolavirus vaccine, ERVEBO; final drug product stored in vendor managed inventory (VMI) and; development of an updated manufacturing process.
Awarded contract 75A50124C00057 to MERCK SHARP & DOHME LLC for 174606743.00 on 2024-09-27.
Notice history
| Notice | Type | Posted |
|---|---|---|
| J&a ervebo | Limited / Sole Source Justification | |
| This notice | Award Notice | |
| Notice of Intent to Sole Source: ERVEBO | Special Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity